Literature DB >> 20511480

New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin.

Joseph I Sirven.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511480      PMCID: PMC2878253          DOI: 10.4065/mcp.2010.0267

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  13 in total

1.  Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history.

Authors:  L Bren
Journal:  FDA Consum       Date:  2001 Mar-Apr

2.  Thalidomide: tragic past and promising future.

Authors:  S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2004-07       Impact factor: 7.616

3.  Off-label prescribing among office-based physicians.

Authors:  David C Radley; Stan N Finkelstein; Randall S Stafford
Journal:  Arch Intern Med       Date:  2006-05-08

4.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

5.  Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.

Authors:  Richard K Bogan; Michel A Cramer Bornemann; Clete A Kushida; Pierre V Trân; Ronald W Barrett
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

6.  Opsoclonus-myoclonus syndrome in patients with locked-in syndrome: a therapeutic porthole with gabapentin.

Authors:  Francesca Pistoia; Massimiliano Conson; Marco Sarà
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

Review 7.  Examination of the evidence for off-label use of gabapentin.

Authors:  Alicia Mack
Journal:  J Manag Care Pharm       Date:  2003 Nov-Dec

8.  The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel.

Authors:  N S Gee; J P Brown; V U Dissanayake; J Offord; R Thurlow; G N Woodruff
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

Review 9.  Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.

Authors:  Kathryn J Macdonald; L Trevor Young
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 10.  Gabapentin: a new agent for the management of epilepsy.

Authors:  C O Andrews; J H Fischer
Journal:  Ann Pharmacother       Date:  1994-10       Impact factor: 3.154

View more
  3 in total

1.  Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities.

Authors:  Sandeep Kumar Gupta; Roopa Prasad Nayak
Journal:  J Pharmacol Pharmacother       Date:  2014-04

Review 2.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

3.  Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury.

Authors:  Khalid C Eldahan; Hannah C Williams; David H Cox; Jenna L Gollihue; Samir P Patel; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2019-10-31       Impact factor: 5.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.